BPC 157 10mg+GHK CU50mg+TB500

Price range: $179.00 through $1,599.00

Wishlist Compare

Batch Number: 2026/02

Purity Percentage: 99.5

Identity Confirmation: Krause Analytics

Testing Methods: HPLC-UV/MS

Credential Line: 145211

Test Date: 09/05/2026

View Lab Result

Research Data

Research Classification

Triple Research Peptide Blend / Multi-Peptide Research Formulation

Molecular Structure

Molecular Structure

Structure Description

This research formulation contains three structurally distinct peptide-based compounds: BPC-157, a 15-amino-acid peptide; GHK-Cu, a copper-coordinated Gly-His-Lys tripeptide complex; and TB-500, an N-terminally acetylated seven-amino-acid fragment corresponding to thymosin β4 residues 17–23. The current analytical report confirmed the identity of all three analytes by HPLC-UV-MS.

Research Discipline

Cell Biology; Peptide Biology; Vascular Biology; Fibroblast Biology; Extracellular-Matrix Biology; Copper-Peptide Research; Molecular Signaling

Molecular Formula

BPC-157: C₆₂H₉₈N₁₆O₂₂ GHK-Cu: Copper-complex formula depends on the specific coordination/speciation represented. PubChem contains GHK-Cu records including C₁₄H₂₁CuN₆O₄⁻; the laboratory COA does not specify the exact copper-complex stoichiometry. TB-500 Free Base: C₃₈H₆₈N₁₀O₁₄

Molecular Weight

BPC-157: 1419.5 g/mol GHK-Cu: Depends on the exact copper-complex species; PubChem reports 400.90 g/mol for one copper-tripeptide record. TB-500 Free Base: 889.01 g/mol

CAS Number

BPC-157: 137525-51-0 GHK-Cu / COA Reported: 49557-75-7 TB-500: 885340-08-9 The first and third identifiers correspond to BPC-157 and TB-500 respectively. The GHK-Cu CAS should be retained as COA-reported because 49557-75-7 is also associated with GHK itself in PubChem rather than uniquely defining every GHK-copper complex.

Amino Acid Sequence

BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val GEPPPGKPADDAGLV GHK-Cu: Gly-His-Lys GHK TB-500: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln Ac-LKKTETQ

Primary Molecular Target

Multiple experimental targets/pathways; no single established shared molecular target Relevant experimental contexts include: BPC-157: vascular and cellular signaling pathways GHK-Cu: copper-dependent cellular signaling, extracellular-matrix and fibroblast-associated pathways TB-500: thymosin β4 fragment / actin-associated research context The combined formulation itself does not have a validated single molecular target.

Experimental Applications

Peptide signaling research
Fibroblast biology
Extracellular-matrix studies
Collagen-associated research
Cellular migration models
Endothelial-cell research
Vascular biology
Copper-peptide research
Cytoskeletal-associated research
Peptide structure-function studies
Cellular remodeling research
Multi-peptide interaction studies

Experimental Systems

Published research involving the individual constituents includes:

Fibroblast cell-culture systems
Endothelial-cell models
Collagen-production models
Extracellular-matrix experimental systems
Copper-peptide biochemical systems
Cellular migration models
Preclinical tissue-response models
Peptide metabolism systems
In vitro biochemical assays

These systems relate to research on the individual compounds and should not be interpreted as validation of the combined three-component formulation.

Specific Assays

HPLC-UV purity analysis
LC-MS identity analysis
Mass-spectral matching
USP endotoxin testing
Fibroblast proliferation assays
Collagen-production assays
Cell-migration assays
Extracellular-matrix expression assays
Metalloproteinase analysis
Endothelial-cell assays
Peptide stability and metabolism assays

GHK-Cu has specifically been evaluated experimentally in fibroblast proliferation and collagen-production models.

Measured Endpoints

Chromatographic purity
Component identity
Individual peptide content
Endotoxin concentration
Fibroblast proliferation
Collagen production
Extracellular-matrix remodeling
Cellular migration
Endothelial-cell response
Metalloproteinase-associated activity
Peptide stability and metabolism

For the actual OPTMZ product, the measured analytical endpoints were purity, identity, individual component content, and endotoxin concentration.

Evidence Level

Preclinical Research The scientific context for these compounds consists primarily of biochemical, cellular, animal, and other preclinical research. Evidence for the three-component formulation itself is more limited than evidence for the individual constituents.

Analytical Characterization

Independent analytical testing of OPTMZ Peptides GLOW, nominally 70 mg total, batch/lot 2026/02, by Krause Analytical reported:

Chromatographic Purity: 99.5%
BPC-157 Content: 10.1 mg
BPC-157 Label Claim: 10 mg
BPC-157 Percent of Label: 101.1%
BPC-157 Identity: Confirmed
GHK-Cu Content: 39.7 mg
GHK-Cu Label Claim: 50 mg
GHK-Cu Percent of Label: 79.3%
GHK-Cu Identity: Confirmed
TB-500 Content: 13.4 mg
TB-500 Label Claim: 10 mg
TB-500 Percent of Label: 133.6%
TB-500 Identity: Confirmed
Analysis Method: HPLC-UV-MS
Endotoxins: <0.5 EU/mL Endotoxin Method: USP
Lab Number: 205074
Project: 145211
Report Issued: May 19, 2026

The laboratory reports that values are per vial unless otherwise noted.

Extra Features
  • Premium Quality
  • Secure Payments
  • Satisfaction Guarantee
  • Worldwide Shipping
  • Money Back Guarantee

Research Use Only

All research peptides supplied by OPTMZ Peptides are intended exclusively for laboratory research applications and are not designed for medical use. These materials are not approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease. By purchasing, the buyer confirms use strictly for scientific research purposes and not for human or animal consumption.

Product Overview

The BPC 157 10mg+GHK+ CU 50mg+TB500 10mg (GLOW Blend) is a combination of multiple research peptides. This blend is examined in controlled laboratory environments for its interaction with cellular signaling pathways, protein-related processes, and biochemical pathway models.

Technical Specifications

GHK-Cu

  • CAS Number: 49557-75-7
  • Molecular Formula: C₁₄H₂₄CuN₆O₄
  • Molecular Weight: 340.9 g/mol
  • PubChem ID: 5311476

BPC-157

  • CAS Number: 137525-51-0
  • Molecular Formula: C₆₂H₉₈N₁₆O₂₂
  • Molecular Weight: 1419.556 g/mol
  • PubChem ID: 108101

TB-500

  • CAS Number: 77591-33-4
  • Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
  • Molecular Weight: 4963.5 g/mol
  • PubChem ID: 16132321
  • Purity: ≥99% (HPLC tested)
  • Form: Lyophilized powder
  • Synthesis Method: Solid-phase peptide synthesis

Analytical & Testing

Each batch of the GLOW Blend undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis to verify purity, identity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for each batch.

Handling & Storage

This peptide blend should be handled by qualified professionals in controlled laboratory environments. Proper storage conditions should be maintained to preserve compound stability and structural integrity.

Research Context

In preclinical and laboratory research models, the GLOW Blend has been examined across structural, dermatological, vascular, and cellular systems. Research focus includes:

  • Collagen-related pathway models
  • Extracellular matrix interactions
  • Angiogenic signaling pathways
  • Cellular signaling mechanisms

These observations are limited to controlled experimental environments and support ongoing laboratory investigations.

Research Application Scope

The BPC 157 10mg+GHK CU50mg+TB500 10mg (GLOW Blend) continues to be evaluated for its relevance in experimental biology, particularly within studies involving multi-peptide interactions, cellular signaling pathways, and biochemical pathway analysis.

Use Statement

For laboratory research use only. Intended strictly for in vitro research applications.

Disclaimer

All products currently listed on this site are for research purposes ONLY.

Pcs

Single pack, Pack of 10

Strength

70mg

Reviews

There are no reviews yet.

Be the first to review “BPC 157 10mg+GHK CU50mg+TB500”

Your email address will not be published. Required fields are marked *